Abstract
Rasmussen syndrome (RS) is a clinical diagnosis characterized by persistent focal seizures in a previously healthy child. Occasionally, the typical features of RS may be followed by another diagnosis. We discuss the course of a 12-year-old girl who presented with RS but was later diagnosed with CNS granulomatous disease and NOD2/CARD15 mutations. Her response to infliximab suggests that it should be included in immune-modulatory therapies used to treat these refractory disorders.
Original language | English (US) |
---|---|
Pages (from-to) | 640-643 |
Number of pages | 4 |
Journal | Neurology |
Volume | 69 |
Issue number | 7 |
DOIs | |
State | Published - Aug 2007 |
Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology